SCHEMBL6014401

SCHEMBL6014401

NC1=CCCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29002294 1.00 KDM1A (0.39)
SCHEMBL18571425 1.00 KDM1A (0.39)
SCHEMBL29002302 1.00 KDM1A (0.39)
SCHEMBL6014396 1.00
SCHEMBL6014655 1.00 KDM1A (0.39)
SCHEMBL2486743 1.00
SCHEMBL14210854 1.00 KDM1A (0.39)
SCHEMBL15904034 1.00
SCHEMBL6014657 1.00 KDM1A (0.39)
SCHEMBL29002315 1.00 KDM1A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036787-A Synthesis of cyclooctenamine linker and application of cyclooctenamine linker in coupled medicine 苏州盛诺维生物科技有限公司 2026-05-15 CN claimed
CN-118546380-A Biodegradable polymer, preparation method and application thereof, and medical filling material 上海发微医用材料有限公司 2024-08-27 CN claimed
US-20240021874-A1 Sulfonimide Salts for Battery Applications MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-01-18 US claimed
EP-3581175-B1 DRUG DRUG DELIVERY FORMULATION FOR TREATING MENTAL ILLNESS OR CENTRAL NERVOUS SYSTEM DISORDER UNIV AJOU IND ACADEMIC COOP FOUND (KR) 2023-12-13 EP claimed
US-10892520-B2 Sulfonimide salts for battery applications MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-01-12 US claimed
WO-2018147660-A1 DRUG DRUG DELIVERY FORMULATION FOR TREATING MENTAL ILLNESS OR CENTRAL NERVOUS SYSTEM DISORDER 아주대학교산학협력단 2018-08-16 WO claimed
US-20180212275-A1 SULFONIMIDE SALTS FOR BATTERY APPLICATIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-07-26 US claimed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP claimed
CN-122036787-A Synthesis of cyclooctenamine linker and application of cyclooctenamine linker in coupled medicine 苏州盛诺维生物科技有限公司 2026-05-15 CN disclosed
CN-122036787-A Synthesis of cyclooctenamine linker and application of cyclooctenamine linker in coupled medicine 苏州盛诺维生物科技有限公司 2026-05-15 CN disclosed
CN-122036787-A Synthesis of cyclooctenamine linker and application of cyclooctenamine linker in coupled medicine 苏州盛诺维生物科技有限公司 2026-05-15 CN disclosed
CN-118546380-A Biodegradable polymer, preparation method and application thereof, and medical filling material 上海发微医用材料有限公司 2024-08-27 CN disclosed
CN-118475662-A Superhydrophobic coatings, compositions, and methods 不列颠哥伦比亚大学 2024-08-09 CN disclosed
US-20240021874-A1 Sulfonimide Salts for Battery Applications MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-01-18 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
US-20040147708-A1 Composition for optical material MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-07-29 US disclosed
EP-1426392-A1 COMPOSITION FOR OPTICAL MATERIAL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-06-09 EP disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed
US-4955901-A HYDROPHILIC SURFACE TREATMENT CANON KABUSHIKI KAISHA (JP) 1990-09-11 US disclosed